I agree We use cookies on this website to help us provide the best user experience. By browsing this site you agree to their use - more information is available here.

Barnett Waddingham
0333 11 11 222
The requirement for strong risk management within insurance companies continues to grow on the back of Solvency II rules coupled with regulatory and stakeholder focus. The ORSA policy has become a central part of a firm’s decision making and strategy processes.

For many, this is a significant journey and we are able to help clients in all steps of the process. Our clients range from small to medium firms looking for a full range of expert advice and support to the largest firms who are typically looking for independent technical and validation support.

We have specific expertise in:

  • ORSA design and implementation
  • embedding ORSA into business processes
  • stress and scenario testing
  • deep-dive independent risk investigations
  • governance structures including Board effectiveness
  • model validation

Related knowledge and resources


  • Picture for The Ogden knock out
    The Ogden knock out

    The Ministry of Justice closed their consultation recently into how the Ogden discount rate should be set in the future. In this blog we will look the core issues examined in the consultation paper and what could happen next.

  • Picture for Q.R.T? N.S.T? H.E.L.P!
    Q.R.T? N.S.T? H.E.L.P!

    Struggling with the Solvency II quantitative reporting templates (QRTs) and UK National Specific Templates (NSTs)? John Hoskin sets out the information that firms need to consider when completing their submissions.

  • Picture for Mutual deferred shares – a panacea to the sector’s difficulties?
    Mutual deferred shares – a panacea to the sector’s difficulties?

    In August HM Treasury issued draft regulations that will enable mutual insurers to raise capital under the powers in the Mutuals’ Deferred Shares Act of 2015. We submitted a response to the consultation which was open until 30 September 2016.

  • Solvency II disclosures

    It may feel like there’s plenty of time before the Solvency and SFCR and RSR submission deadlines, but the scattered nature of the regulation and the high volume of information required make the task of preparing the reports far from trivial.

  • Response on TR16/2: Fair treatment of long-standing customers in the life insurance sector

    We welcome the effort that the FCA has put into the TR16/2 review. Focusing on good customer outcomes has always been important for well-run life insurers and we agree on the importance of considering all customers throughout the duration of their policy.

  • A new dawn for with-profits business

    With-profits business has been a major part of the UK life insurance market for many generations. It remains a critical component of many insurers’ existing and new business despite regular ill-informed criticism and reports of its imminent demise.

  • Achieving higher returns with lower risk

    We were appointed to advise a client with ~£400m of assets in 2015 and this case study sets out how we worked with the trustees and employer to ultimately reduce risk and increase expected returns while working towards an agreed objective.

  • An out of control deficit

    We provide a regular funding and investment monitoring service to the trustees of a £40m scheme. We were asked to review the funding and investment strategies of the scheme, in particular with a view of reducing the risk of the deficit increasing further.

  • Contingency planning in action

    A client was looking to develop a financial management plan for the scheme, targeting a fully de-risked and liability matched investment strategy and moving on to buy-out. The plan aimed to strike a balance between reducing risk and business needs.

Barnett Waddingham Comment and Insight
Comment and insight

Read all our views into the latest industry developments and hot topics

Click here

Register for your choice of email alerts

Stay ahead with our latest comment, expert insight and event details.